Rohde & Schwarz announced today it has transferred its DOCSIS portfolio with the worldwide distribution rights, to Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions.
Rohde & Schwarz and Calian have been partners since June 2011 and have jointly developed test and measurement instruments for DOCSIS. The transfer of the DOCSIS product portfolio to Calian demonstrates Calian’s commitment to growth in this industry.
Werner Dürport, Product Manager at Rohde & Schwarz and responsible for the DOCSIS portfolio, says: “As we hand over our DOCSIS portfolio to Calian, we want to assure our customers that their needs remain our top priority. Calian has been a trusted partner since 2011, and their commitment to excellence in delivering technical solutions and products aligns with our own values. Calian will continue to provide the high level of service and support that our customers expect. We believe this move is in the best interest of our customers, especially with the continued evolution of DOCSIS technology.”
Calian delivers top-tier DOCSIS test and measurement products, and specializes in RF and physical layer diagnostics suitable for laboratory testing and in-field monitoring. Dan Coode, Vice President of Terrestrial at Calian’s Advanced Technologies business unit, says: “We want this transition to be as seamless as possible, and customers can expect to continue to receive the same excellent customer service they had at Rohde & Schwarz. We are very excited to expand our portfolio with these exceptional Rohde & Schwarz products and make them our own.”
Rights for the aforementioned products will formally transfer to Calian effective August 1, 2024. Product warranties will remain in effect for their full duration, and Calian will provide long term product support. For information on distribution and warranty periods, customers can contact their Rohde & Schwarz or Calian representatives.
